Friday, December 12, 2025
HomeIndustriesBiotechnology

Biotechnology

Zhimeng Biopharma Announces Dosing of First Subject of Its Novel Antiepileptic Drug Candidate CB03 in First-in-Human Phase I Clinical Trial

Shanghai Zhimeng Biopharma, Inc. ("Zhimeng"), announced dosing of the first participant in the US Phase I study in healthy subjects of its innovative small-molecule...

Strata Oncology Enrolls First Patient in Strata PATH Trial Investigating New Pan-Tumor Indications for Approved Cancer Therapies

Strata Oncology, Inc., a next-generation precision oncology company enabling smarter and earlier cancer treatment, announced enrollment of the first patient in the Strata Precision...

Top 3 Diagnostics Technology Advancements in Healthcare in 2024

Diagnostics are the foundation of disease detection, diagnosis, and assessment. Diagnostics inform more than 70% of medical decisions about disease treatment, management, and prevention....

Rational Vaccines’ Herpes Vaccine RVx1001 Shows Promise as a Viral Vector Platform to Express Malaria Proteins and Confer Protection

Rational Vaccines, a company focused on revolutionizing the treatment and prevention of herpes to eradicate the disease, announced that the Company's attenuated herpes simplex...

Bergen New Bridge Medical Center Signs with Guardian Research Network to Help Change How Healthcare is Delivered

Guardian Research Network Inc. announced that Bergen New Bridge Medical Center, New Jersey's largest hospital and a clinical affiliate of Rutgers University Medical School,...
0FansLike
0FollowersFollow
spot_img

Hot Topics